Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04450927|
Recruitment Status : Recruiting
First Posted : June 30, 2020
Last Update Posted : July 10, 2020
Researchers seek ways to study people s medical problems in order to teach and further general knowledge. The ability to assess and treat people with a wide range of diseases is critical to training people to be good doctors. It is also needed to keep medical staff up to date. In this study, researchers want to study the course of some illnesses to learn more about them. To do this, they will collect and review people s medical records. In some cases, they may also provide treatment.
To collect data that may be used to help researchers create ideas for future research.
People age 2 and older who have or are suspected to have a medical condition for which they have been referred to NIH s National Heart, Lung, and Blood Institute, as well as stem cell donors
Participants may be screened with a review of the following:
Scans and images
Other existing samples and reports.
Participants medical data will be collected from the standard care they receive. This includes their routine blood and urine tests, X-rays and scans, and other tests to diagnose or follow their medical condition. Data will also be collected from the treatments they may receive. For stem cell donors, data from apheresis procedures will be collected. Demographic data will also be collected.
All of the data will be kept in the medical records or on secure network drives.
Some participants may need to be treated for their medical condition. If so, they will sign a separate consent form for that treatment.
Participation lasts up to 2 years.
|Condition or disease|
|Wide Spectrum of Diseases Hematologic Diseases|
|Study Type :||Observational|
|Estimated Enrollment :||10000 participants|
|Official Title:||Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors|
|Actual Study Start Date :||June 16, 2020|
|Estimated Primary Completion Date :||March 31, 2030|
|Estimated Study Completion Date :||December 31, 2040|
Data collection and treatment according to guidelines of standard of medical evaluation and care. No investigational treatments or procedures will be administered on this protocol.
- To provide a repository of information on enrolled participants to allow for hypothesis generation in future research [ Time Frame: 20 years ]To provide a repository of information on enrolled participants to allow for hypothesis generation in future research
- To add value to the NHLBI training program [ Time Frame: 20 years ]To add value to the NHLBI training program by providing consult, treatment, diagnostic tests, and medicalfollow-up of participants
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04450927
|Contact: Georg Aue, M.D.||(301) email@example.com|
|United States, Maryland|
|National Institutes of Health Clinical Center||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 firstname.lastname@example.org|
|Principal Investigator:||Georg Aue, M.D.||National Heart, Lung, and Blood Institute (NHLBI)|